Andre Kalil
Impact in
-
- Nosocomial Infections in ICU
- Infectious Diseases top 0.1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Nosocomial Infections in ICU 44
- Epidemiology 137
- Sepsis Diagnosis and Treatment 55
- Cytomegalovirus and herpesvirus research 29
- Pneumonia and Respiratory Infections 27
- Fungal Infections and Studies 15
- Co-authors
- Diana F. Florescu (59 shared papers)Michael Klompas (14 shared papers)Paul D. Fey (6 shared papers)Daniel A. Sweeney (20 shared papers)Naomi P. O’Grady (6 shared papers)John Gilles Bartlett (3 shared papers)Mark L. Metersky (9 shared papers)Paul Glyndwr Thomas (1 shared paper)
- Journals
- Critical Care Medicine (49 papers)Clinical Infectious Diseases (27 papers)Clinical Microbiology and Infection (14 papers)Intensive Care Medicine (13 papers)Transplantation (8 papers)
- Partner nations
- United StatesFranceBrazil
In The Last Decade
Andre Kalil
263 papers receiving 19.7k citations
Andre Kalil's Hit Papers
Peers
Comparison fields: 5 of 182
- Critical Care and Intensive Care Medicine 2.6k
- Infectious Diseases 7.6k
- Applied Microbiology and Biotechnology 758
- Epidemiology 6.2k
- Molecular Medicine 914
Countries citing papers authored by Andre Kalil
This map shows the geographic impact of Andre Kalil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andre Kalil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andre Kalil more than expected).
Fields of papers citing papers by Andre Kalil
This network shows the impact of papers produced by Andre Kalil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andre Kalil. The network helps show where Andre Kalil may publish in the future.
Co-authors
The 25 scholars most cited alongside Andre Kalil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 276 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Remdesivir for the Treatment of Covid-19 — Final Report Hit paper breakdown → | 2020 | 5571 |
| 2 | Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society Hit paper breakdown → | 2016 | 2787 |
| 3 | Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 Hit paper breakdown → | 2020 | 1402 |
| 4 | Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis Hit paper breakdown → | 2013 | 681 |
| 5 | 2008 | 437 | |
| 6 | Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics Hit paper breakdown → | 2020 | 387 |
| 7 | Influenza virus-related critical illness: pathophysiology and epidemiology Hit paper breakdown → | 2019 | 373 |
| 8 | Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society Hit paper breakdown → | 2016 | 330 |
| 9 | 2005 | 319 | |
| 10 | 2002 | 289 | |
| 11 | 2003 | 241 | |
| 12 | 2020 | 232 | |
| 13 | 2007 | 210 | |
| 14 | 2005 | 203 | |
| 15 | 2020 | 192 | |
| 16 | How to use biomarkers of infection or sepsis at the bedside: guide to clinicians Hit paper breakdown → | 2023 | 184 |
| 17 | 2009 | 169 | |
| 18 | 2019 | 162 | |
| 19 | 2017 | 146 | |
| 20 | 2014 | 144 |
About Andre Kalil
Andre Kalil is a scholar working on Critical Care and Intensive Care Medicine, Epidemiology, Infectious Diseases, Clinical Biochemistry and Applied Microbiology and Biotechnology, having authored 276 papers that have together received 20.5k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (55 papers), Nosocomial Infections in ICU (44 papers), Cytomegalovirus and herpesvirus research (29 papers), Pneumonia and Respiratory Infections (27 papers), COVID-19 Clinical Research Studies (25 papers), Fungal Infections and Studies (15 papers), Respiratory Support and Mechanisms (14 papers) and Bacterial Identification and Susceptibility Testing (13 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (2.6k citations), Infectious Diseases (7.6k citations), Applied Microbiology and Biotechnology (758 citations), Epidemiology (6.2k citations) and Molecular Medicine (914 citations). Andre Kalil has collaborated with scholars based in United States, France and Brazil. Frequent co-authors include Diana F. Florescu, Michael Klompas, Paul D. Fey, Daniel A. Sweeney, Naomi P. O’Grady, John Gilles Bartlett, Mark L. Metersky, Paul Glyndwr Thomas, Alison G. Freifeld and GRANT W. WATERER. Their work appears in journals such as Critical Care Medicine, Clinical Infectious Diseases, Clinical Microbiology and Infection, Intensive Care Medicine and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.